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Abstract
Background—Individuals with congenital heart defects (CHDs) have high hospital resource use. 
We sought to identify factors associated with hospital costs and multiple hospitalizations among 
individuals with CHDs.
Methods—Data from the 2006 to 2011 Healthcare Cost and Utilization Project Arkansas State 
Inpatient Databases were linked across encrypted patient identifiers to develop a cohort of 
Arkansas residents aged 1 to 64 years who were hospitalized at least once with a CHD during this 
time period. Infants were excluded because patient identifiers were missing for 18 to 52% each 
year. CHDs were identified using principal and secondary International Classification of Diseases, 
Ninth Revision, Clinical Modification diagnoses codes. All hospitalizations of individuals ever 
admitted with a CHD were included. Mean and median patient-level costs were estimated; the 
association of hospital costs and patient readmissions were examined with linear and logistic 
regression.
Results—There were 1,185,868 inpatient hospitalizations of Arkansas residents aged 1 to 64 
years between 2006 and 2011; these were accrued by 603,925 patients. Of those, 2542 patients 
(0.42%) had at least one hospitalization with a CHD diagnosis. Total costs for these 2542 patients 
were $126,999,837 and they accumulated 7898 hospitalizations. Factors associated with increased 
costs included patient age, CHD type, cardiac procedures, and comorbidities. Factors associated 
with hospital readmission within 1 year included age, CHD type, expected payer, and 
comorbidities.
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Conclusion—Individuals with CHDs in Arkansas experience variation in hospital use and costs 
by patient characteristics. Future research should investigate factors associated with readmissions, 
cardiac procedures, and comorbidities, as these are strongly associated with hospital costs.
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Introduction
Congenital heart defects (CHDs) are a relatively common birth defect affecting 
approximately 8 to 10 per 1000 infants (Reller et al., 2008; Bjornard et al., 2013). Survival 
among infants born with CHD has improved over time (Oster et al., 2013). Currently, it is 
estimated that more adults (over the age of 18 years) than children are living with a CHD in 
the United States (Warnes et al., 2001); moreover, the number of hospitalizations of adults 
with CHD is increasing compared with hospitalizations of children with CHD (O’Leary et 
al., 2013). The medical needs of patients with CHD beyond infancy are largely unknown. A 
better understanding of the patient-level hospital resource use of children and adults with 
CHD is needed.
At the hospital level, hospitalizations of individuals with CHD have high costs in both 
pediatric and adult admissions (Connor et al., 2005; Opotowsky et al., 2009; O’Leary et al., 
2013; Simeone et al., 2014). Additionally, hospital costs are influenced by age, CHD 
complexity, payer status, hospital or surgical center, and complications during treatment 
(Connor et al., 2005; Benavidez et al., 2007; Pasquali et al., 2011, 2014). A hospital-level 
analysis of hospitalization costs for CHDs found that across the life-span CHDs accounted 
for approximately 0.4% of hospitalizations and 2.2% of hospital costs (Simeone et al., 
2015).
To address the gap in knowledge, we aim to describe the patient-level hospital use and costs 
for individuals aged 1 to 64 years with a CHD diagnosis and to identify factors associated 
with higher hospital costs and multiple hospitalizations among patients with CHDs admitted 
to Arkansas hospitals between 2006 and 2011. This builds on earlier work to examine 
hospital-level costs for Arkansas patients of all ages with CHDs (Simeone et al., 2015).
Materials and Methods
DATA SOURCE
This was a longitudinal study of hospitalizations of Arkansas residents with CHD admitted 
to Arkansas acute care hospitals between 2006 and 2011. Data were obtained from the 
Agency for Healthcare Research and Quality’s 2006 to 2011 Arkansas State Inpatient 
Databases (SID), a set of inpatient all-payer administrative databases of hospital discharges 
(AHRQ, 2013b, 2014b). The Arkansas SID provides encrypted patient identifiers (PI), 
which allow linkage of inpatient admissions at the patient level (AHRQ, 2014a, 2015).
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CASE DEFINITION AND STUDY VARIABLES
We included hospitalizations of individuals aged 1 to 64 years admitted between January 1, 
2006 and December 31, 2011 with at least one hospitalization discharge record including a 
principal or secondary CHD International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) diagnosis code (745.0–747.49). We defined critical 
CHDs (CCHD) as the following CHD phenotypes, which are primary and secondary targets 
of newborn screening for CCHD using pulse oximetry: hypoplastic left heart syndrome 
(746.7), pulmonary atresia (746.01), tetralogy of Fallot (745.2), total anomalous pulmonary 
venous return (747.41), transposition of the great arteries (745.10), tricuspid atresia (746.1), 
truncus arteriosus (745.0), double outlet right ventricle (745.11), single ventricle (745.3), 
Ebstein anomaly (746.2), coarctation/hypoplasia of aortic arch (747.10), and aortic 
interruption/atresia/hypoplasia (747.11, 747.22) (Mahle et al., 2009; Kemper et al., 2011). 
Patients who ever had an ICD-9-CM code indicating a CCHD or non-critical CHD during 
the study period (2006–2011) were considered to have a CHD even if previous or 
subsequent hospitalization during the study period did not include a CHD ICD-9-CM code.
We excluded hospitalizations of infants (patients <1 year of age), of patients ≥ 65 years of 
age, and of out of state residents; we also excluded those with missing data on age, hospital 
charges, state of residence, length of stay, payer, or PI. Hospitalizations missing length of 
stay were excluded because patient linkage and estimates of time between hospitalizations 
could not be calculated without length of stay. While infants incur approximately three-
quarters of all hospital costs for CHDs (Simeone et al., 2015), hospitalizations of infants 
were excluded from this analysis because of the large number of infant hospitalizations 
without a verified PI in each year (17.8–51.9% each year), preventing the identification of 
individual patients (AHRQ, 2015). After excluding these hospitalizations, the PI was used to 
identify all hospitalizations for unique individuals; patients who never had a hospitalization 
that included at least one ICD-9-CM for a CHD were excluded from the analysis.
Variables of interest for the analysis included patient age, race at first hospitalization (non-
Hispanic white, non-Hispanic black, and other race), sex, expected primary payer (public 
[Medicare and Medicaid], private, and other [self-pay, no charge, and other payer]), urban/
rural residence (based on the 2006 National Center for Health Statistics Urban-Rural 
classification scheme [Ingram et al., 2012], provided in Healthcare Cost and Utilization 
Project data), greater than one hospitalization within a 365-day period, performance of a 
cardiac procedure at any hospitalization (Supp Table 1, which is available online), and 
number of comorbidities. Comorbidities were defined using the Elixhauser comorbidity 
measures, which measure coexisting conditions on the discharge record. These comorbidity 
measures were developed for use with administrative datasets and take into account ICD-9-
CM codes on the discharge record, principal diagnosis, and diagnosis related groups 
(Elixhauser et al., 1998; Healthcare Cost and Utilization Project, 2013). Separate comorbid 
conditions were counted once, regardless of the number of hospitalizations in which they 
occurred. Total number of hospitalizations was calculated by summing the unique hospital 
visits accumulated by each individual; consecutive hospitalizations in which the discharge 
date of the first hospitalization was the same as or overlapped the admission date of the 
second hospitalization were considered one hospitalization.
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Total hospital charges are reported on each discharge record in the SID. Total hospital 
charges on each discharge record were multiplied by hospital- and year-specific cost-to-
charge ratios provided by HCUP (AHRQ, 2013a). Methods have been described in detail 
elsewhere (Simeone et al., 2015). Costs are reported in 2012 U.S. dollars calculated using 
the Purchaser Price Index for Hospitals (U.S. Bureau of Labor Statistics).
STATISTICAL ANALYSIS
The total and per-patient mean and median costs for all individuals who had at least one 
CHD hospitalization and were between 1 and 64 years of age were estimated. Mean patient-
level costs were compared using t tests or analysis of variance; median costs were compared 
using the Wilcoxon-Mann-Whitney or Kruskal-Wallis tests for nonparametric distributions. 
Because the distribution of costs was skewed toward higher costs, linear regression analysis 
was used to estimate the association between demographic characteristics and the natural 
logarithm of patient costs (ln(costs)). Results of the linear regression analysis are presented 
as exp(β); these exponentiated coefficients can be interpreted as percent changes in cost 
associated with a unit change in the independent variables in the model. Per-person costs 
and number of hospitalizations associated with Elixhauser comorbidities were also 
estimated; logistic regression was used to examine which comorbidities were most strongly 
associated with multiple hospitalizations within a 365-day period.
In addition, adjusted logistic regression analysis was used to estimate the adjusted odds 
ratios (ORs) for the association between multiple hospitalizations (≥ 2 hospitalizations) 
within a 365-day period and patient factors, with analysis limited to individuals who did not 
die in their first hospitalization and who had their first hospitalization before 2011. One sub-
analysis was conducted, examining mean hospital costs among patients ever experiencing a 
cardiac procedure; linear regression of ln(costs) of hospital costs, by age group, was used to 
examine the impact of cardiac procedures on costs. In analyses, patients 4 to 17 years were 
selected a priori as the referent group because we hypothesized this group would use the 
least resources because the majority of costly CHD surgical repairs were anticipated to occur 
in children before 4 years of age, with any additional repairs occurring later in adulthood.
Inclusion criteria may have resulted in an overestimation of the number of individuals aged 
1 to 64 years hospitalized with a CHD due to misclassification of individuals with numerous 
comorbidities and acquired heart disease as having a CHD, particularly among individuals 
with seemingly minor CHDs, such as atrial septal defects. We conducted a sensitivity 
analysis restricting the study population. The population for the sensitivity analysis was 
developed using inclusion and exclusion criteria to exclude subjects whose primary source 
of morbidity was unlikely to be a CHD. All patients who were ever diagnosed with a 
CCHD, ever had a principal diagnosis of a CHD, or those ever diagnosed with a CHD who 
also had a cardiac procedure during the same hospitalization were included, regardless of 
any additional diagnoses. Any patient without a CCHD, without a principal diagnosis of a 
CHD, or without a CHD diagnosis and cardiac procedure during the same hospitalization 
were considered for the sensitivity exclusion. Sensitivity exclusion criteria were diagnosis of 
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ischemic heart disease (ICD-9-CM 410.xx-414.xx), diabetes (ICD-9-CM 250.xx), or sickle 
cell disease (ICD-9-CM 282.41-282.42, 282.6) (Supp. Fig. 1).
Results
After excluding hospitalizations of infants (n = 269,809), of patients ≥ 65 years of age (n = 
947,229), and of out of state residents (n = 63,107), as well as hospitalizations missing data 
on age at admission (n = 1193), hospital charges (n = 2189), residence (n = 275), length of 
stay (n = 224), payer status (n = 15,284), and PI (n = 38,118), there were 1,185,868 
hospitalizations available for patient-level analysis. These hospitalizations were accumulated 
by 603,925 individual patients, 2542 (0.42%) of whom had at least one hospitalization with 
a CHD diagnosis (Supp. Fig. 2).
The total 2006 to 2011 hospital costs of the 2542 individuals aged 1 to 64 years were 
$126,999,837 and these patients accumulated 7898 hospitalizations with and without a CHD 
diagnosis between 2006 and 2011. Of those 7898 hospitalizations, 4866 (61.6%) had no 
CHD diagnosis, 761 (9.6%) included the CHD as the principal diagnosis, and 2271 (28.5%) 
included the CHD as a secondary diagnosis. Average per-patient cost was $49,961 (standard 
error [SE]: 1626). Median per-patient hospital costs for all hospitalizations were $28,482 
(interquartile range [IQR]: $10,899, $53,530). Among hospitalizations of individuals ever 
admitted with CHD but with no CHD diagnosis, per-hospitalization mean costs were 
$10,289 (SE = 322); median costs were $5505 (IQR = $3174, $10,097). Hospitalizations in 
which the CHD was the principal diagnosis had mean per-hospitalization costs of $36,736 
(SE = 1587) and median costs of $29,104 (IQR = $12,722, $44,211). Hospitalizations in 
which the CHD was a secondary diagnosis had mean per-hospitalization costs of $17,433 
(SE = 920) and median costs of $6651 (IQR = $3482, $17,364).
Thirty-eight percent of patients ever admitted with a CHD between 2006 and 2011 were 46 
to 64 years old at their first admission (Table 1). Patients with CCHDs comprised 13.4% of 
all individuals ever hospitalized with CHD over the study period. Of patients ever admitted 
with a CHD between 2006 and 2011, 45.5% had an expected private payer, 49.1% 
experienced multiple inpatient hospitalizations within 365 days, 38.6% had ever undergone 
a prior cardiac procedure, and 28.8% of patients were ever admitted with a CHD as the 
principal diagnosis. By demographic characteristic, children aged 1 to 3 years at their first 
admission during this time period had more costly hospitalizations compared with patients at 
older ages at their first admission; non-Hispanic black patients had more costly 
hospitalizations than patients of other races; patients with an expected public payer had more 
costly hospitalizations than patients with private or other expected payers; patients ever 
admitted with a CHD as the principal diagnosis had more costly hospitalizations than 
patients who were never admitted with a CHD as the principal diagnosis.
In an adjusted linear regression, several patient factors were associated with increased 
hospital costs (Table 2). Hospital costs were nearly 1.5 times higher in those with a CCHD 
compared with those without a CCHD. Multiple hospitalizations within 365 days more than 
doubled hospital costs compared with patients with no more than one hospitalization within 
any 365-day period. A history of at least one cardiac procedure during the study period 
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nearly tripled hospital costs. Cardiac procedures were associated with higher hospital costs 
at all ages (Supp Table 2). Cardiac procedures were more common among patients less than 
18 years of age compared with patients 18 to 64 years of age. Similarly, mean per-patient 
hospital costs were highest in pediatric hospitalizations. Among patients aged 1 to 3 years, 
hospital costs of patients with a cardiac procedure were over 4 times higher than hospital 
costs of patients of the same age without a procedure (Supp Table 2). Older age at first 
admission and female sex were both associated with decreased per-patient costs (Table 2).
In an adjusted logistic regression, patients aged 1 to 3 years and 18 to 45 years at their first 
admission were 1.84 and 1.63 times more likely to experience multiple hospitalizations 
within 365 days compared with patients aged 4 to 17 years at their first admission (Table 3). 
Elevated ORs for multiple hospitalizations within 365 days were also observed among 
patients with CCHDs, patients with an expected public payer, and patients with a greater 
number of comorbid conditions. A history of at least one cardiac procedure during the study 
period was not associated with multiple admissions.
Among all patients ever admitted with a CHD, 1750 (68.8%) patients were admitted with at 
least one Elixhauser comorbidity measure (Table 1). Hypertension-related comorbidities 
were most common (40.2% of patients), followed by fluid and electrolyte disorders (23.3% 
of patients) and chronic pulmonary disease (18.8% of patients) (Table 4). Patients ever 
diagnosed with congestive heart failure had the highest mean per-patient costs and number 
of hospitalizations. Having multiple admissions within 365 days was most strongly 
associated with the presence of congestive heart failure (OR=7.5, 95% confidence interval 
[CI], 5.2–10.2), depression (OR=6.4, 95% CI, 4.6–8.9), and deficiency anemias (OR=5.8, 
95% CI, 4.3–7.7).
When a sensitivity analysis was performed excluding individuals whose hospital costs might 
have been primarily due to other illnesses and not a CHD (n = 524), total per-patient costs 
among individuals whose hospitalizations were not due to other illnesses were $98,067,250; 
mean (SE) costs were $48,596 ($1832) with median (IQR) costs of $28,218 ($10,540–
$51,650). The total number of hospitalizations in the remaining 2018 patients decreased to 
5265 (mean 2.6 [0.7] hospitalizations per patient). Adjusted linear regression of ln(cost) 
associations and estimated adjusted ORs were similar to those observed in the full analysis 
(data not shown).
DISCUSSION
Arkansas children and adults with CHDs experience variation in hospital use and costs by 
demographic factors and comorbidities. Adults over the age of 45 at first hospitalization 
between 2006 and 2011 accounted for the largest patient group, but infants and children 
aged 1 to 3 years had the highest average per-patient costs. Approximately half of patients 
with a CHD had multiple hospitalizations within 365 days of each other. After adjusting for 
patient demographic characteristics, factors associated with increased costs were hospital 
readmission within 1 year, presence of a CCHD, cardiac procedures, and increased number 
of comorbidities. Additionally, having multiple hospitalizations within 365 days was 
associated with having a CCHD, having an expected public payer, and having additional 
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comorbidities. Congestive heart failure was associated with high costs and multiple 
admissions within a 365-day period. While presence of a cardiac procedure at any age 
increased costs, cardiac procedures occurring in childhood had the largest impact on costs.
Previous studies have demonstrated higher costs and associated resource usage in those 
patients with CHDs whose hospitalizations included CCHDs (Mackie et al., 2007; Simeone 
et al., 2014), hospitalizations during infancy and childhood (Connor et al., 2005; Simeone et 
al., 2014), complex surgical procedures (Connor et al., 2005; Pasquali et al., 2011), or in 
which a complication occurred (Benavidez et al., 2007). Our results add to the literature by 
demonstrating that individuals with multiple hospitalizations account for a meaningful 
proportion of patients with CHD and are associated with greater hospital costs.
Adults with a CHD diagnosis comprise a large proportion of the Arkansas inpatient 
population with CHD. This pattern is seen at both the patient and hospital level (Simeone et 
al., 2015). This observation also follows trends of increasing numbers of adult 
hospitalizations with CHD, which are likely the result of improvements in diagnosis and 
treatment in infancy and childhood (Warnes et al., 2001; Marelli et al., 2007, 2014; Oster et 
al., 2013). Understanding the medical needs of this growing patient population will impact 
resource allocation and planning within hospital and healthcare systems.
This study was limited by several factors. Inclusion and exclusion criteria were developed to 
be inclusive; patients were included if at least one hospital discharge during this 6-year 
period included a diagnosis of any CHD. This may have led to an overestimation of costs 
and patient hospitalizations, particularly among those individuals who were high resource 
users, but had very few hospitalizations that included a CHD diagnosis. In a sensitivity 
analysis, we excluded patients whose primary morbidity seemed unlikely be a CHD; total 
costs and number of hospitalizations were reduced by 22.8% and 33.3%, respectively, but 
associations between costs, multiple hospitalizations, and patient characteristics did not 
change. Additionally, our study was constrained by inherent limitations of administrative 
datasets. ICD-9-CM codes were used to identify any hospitalization and patient for whom a 
CHD diagnosis was ever coded and CHDs are prone to misclassification (Frohnert et al., 
2005; Strickland et al., 2008). Patients might have been misclassified as having or not 
having a CHD depending on what was recorded on discharge summaries; this is particularly 
important for the adult population with CHD, where the ICD-9-CM code may be less likely 
to be noted and nonspecific cardiovascular disease codes might be used instead. Due to lack 
of encrypted PI among infants, we were unable to estimate patient-level infant costs. Infants 
accounted for a large proportion of the hospitalizations and costs for CHDs in Arkansas and 
nationwide (Connor et al., 2005; Simeone et al., 2014, 2015); excluding hospitalizations of 
patients less than a year old underestimated patient-level CHD costs, particularly for patients 
with complex surgeries occurring in the first year of life (Moons et al., 2009; Burstein et al., 
2011; Pasquali et al., 2011). Finally, cost data in the SID may be underestimated, as 
physician fees are not included in the discharge summary (Rogowski, 1998).
Despite these limitations, we were able to analyze patient-level data over multiple years 
from a large, population-based, all-payer system. The availability of patient-level identifiers 
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allowed an investigation of per-patient characteristics and costs, which are often unavailable 
with administrative data.
Conclusions
In an analysis of state inpatient hospital costs, patients with CHDs were more likely to have 
higher costs when they had a more severe CHD, comorbidities, cardiac procedures, or 
multiple hospitalizations within 365 days. CCHDs, presence of comorbidities, and having a 
public payer were associated with increased odds of multiple stays within 365 days. Future 
research should investigate factors associated with multiple hospitalizations, need for 
cardiac procedures, and comorbidities in the CHD population, as these appear to be strongly 
associated with hospital costs.
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TABLE 1
Patient-Level Analysis of Demographic Characteristics and Mean and Median Costs of Individuals Aged 1 to 
64 Ever Diagnosed with a Congenital Heart Defect and Admitted to a Hospital, Arkansas State Inpatient 
Databases 2006 to 2011a
N (%)
Mean per-patient








Age at first hospitalization
  1–3 years 321 (12.6) 73,767 (7,482) 38,400 (14,436 – 72,077)
  4–17 years 362 (14.2) 63,801 (5,551) 37,401 (19,897 – 60,265) <0.0001 <0.0001
  18–45 years 882 (34.7) 39,672 (2,138) 19,678 (8,208 – 43,608)
  46–64 years 977 (38.4) 46,299 (1,883) 28,884 (12,511 – 53,264)
Race
  Non-Hispanic white 2,049 (80.6) 47,456 (1,634) 27,722 (10,596 – 51,594)
  Non-Hispanic black 356 (14.0) 67,675 (6,537) 33,793 (13,485 – 64,907) <0.0001 0.0029
  Other 133 (5.2) 42,074 (4,357) 25,370 (10,034 – 51,089)
  Missing 4 (0.2)
Critical congenital heart defect
  No 2,201 (86.6) 44,276 (1,508) 25,905 (10,390 – 48,016) <0.0001 <0.0001
  Yes 341 (13.4) 86,649 (6,904) 54,107 (25,152 – 99,566)
Sex
  Male 1,262 (49.7) 50,812 (2,009) 31,098 (12,240 – 56,709) 0.6032 <0.0001
  Female 1,280 (50.4) 49,121 (2,550) 25,366 (9,965 – 50,073)
Expected payer at first visit
  Public 990 (39.0) 60,541 (3,312) 33,071 (12,891 – 62,065)
  Private 1,156 (45.5) 44,767 (1,968) 26,260 (10,763 – 48,595) <0.0001 <0.0001
  Other 396 (15.6) 38,671 (2,485) 23,949 (9,142 – 46,704)
Residence at first visit
  Rural 974 (38.3) 49,289 (2,537) 28,461 (12,392 – 52,942) 0.7401 0.5063
  Urban 1,566 (61.6) 50,399 (2,115) 28,525 (10,375 – 54,467)
  Missing 2 (0.1)
Multiple hospitalizations within 365 daysc
  No 1,147 (50.9) 28,786 (1,587) 17,425 (6,734 – 35,081) <0.0001 <0.0001
  Yes 1,107 (49.1) 75,359 (3,082) 44,505 (23,662 – 84,831)
Cardiac procedured
  No 1,560 (61.4) 38,829 (1,790) 16,508 (6,992 – 41,802) <0.0001 <0.0001
  Yes 982 (38.6) 67,645 (3,018) 42,299 (28,471 – 68,393)
Number of comorbiditiese
  0 comorbidities 792 (31.2) 29,722 (1,321) 20,193 (7,942 – 37,838)
  1 comorbidity 501 (19.7) 42,061 (3,230) 21,474 (7,436 – 45,287) <0.0001 <0.0001
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N (%)
Mean per-patient








  2 comorbidities 380 (15.0) 43,907 (4,778) 24,826 (11,452 – 43,888)
  3+ comorbidities 869 (34.2) 75,607 (3,479) 46,259 (22,703 – 83,564)
CHD as principal diagnosisf
  No 1,809 (71.2) 47,543 (1,877) 23,464 (8,409 – 50,977) 0.0195 <0.0001
  Yes 733 (28.8) 55,926 (3,204) 35,458 (21,474 – 58,511)
a
Excludes hospitalizations of patients who were less than one year of age at their first hospitalization, greater than 64 years of age at their first 
hospitalization, non-Arkansas residents, as well as patients missing data on age, hospital charges, residence, length of stay, payer status, and 
encrypted patient identifier; after combining hospitalizations by patient identifier, the patient population excludes 601,352 individuals without any 
congenital heart defect diagnosis at any hospitalization.
b
Costs have been adjusted to 2012 dollars using the Purchaser Price Index for Hospitals.
c
Excludes 288 patients who died during their first hospitalization or who were admitted for the first time in 2011.
d
At least one inpatient cardiac procedure during any hospitalization.
e
Comorbidities defined using the Elixhauser comorbidity measures; separate comorbid conditions were counted once regardless of the number of 
hospitalizations in which they were diagnosed.
f
Ever had a hospitalization in which the CHD was the principal diagnosis.
SE, standard error.
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TABLE 2
Patient-Level Analysis of Factors Contributing to Costs, Assessed with Adjusted Multiple Linear Regression 




Age at first hospitalization
  1–3 years 0.98 (0.86, 1.12)
  4–17 years Ref
  18–45 years 0.65 (0.58, 0.74)
  46–64 years 0.73 (0.64, 0.82)
Race
  Non-Hispanic white Ref
  Non-Hispanic black 1.16 (1.05, 1.28)
  Other 1.09 (0.93, 1.27)
Critical congenital heart defect
  No Ref
  Yes 1.47 (1.32, 1.63)
Sex
  Male Ref
  Female 0.90 (0.84, 0.97)
Expected payer at first visit
  Public 0.99 (0.92, 1.08)
  Private Ref
  Other 1.00 (0.90, 1.11)
Residence at first visit
  Rural Ref
  Urban 1.04 (0.97, 1.12)
Multiple hospitalizations within 365 days
  No Ref
  Yes 2.26 (2.09, 2.45)
Cardiac procedurea
  No Ref
  Yes 2.79 (2.59, 3.02)
Number of comorbiditiesb
  0 comorbidities Ref
  1 comorbidity 1.20 (1.08, 1.33)
  2 comorbidities 1.33 (1.18, 1.50)
  3+ comorbidities 2.29 (2.05, 2.57)
Bolded font indicates significant at P < 0.05 level; model adjusted for all variables listed in table as well as year at first hospitalization; results have 
been exponentiated.
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a
At least one inpatient cardiac procedure during any hospitalization.
b
Comorbidities defined using the Elixhauser comorbidity measures; separate comorbid conditions were counted once regardless of the number of 
hospitalizations in which they were diagnosed.
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TABLE 3
Patient-Level Analyses of Associations between Patient Characteristics and Multiple Hospitalizations within 
365 Days, Arkansas State Inpatient Databases, 2006 to 2011





  1–3 years 1.83 (1.26, 2.67)
  4–17 years Ref
  18–45 years 1.61 (1.14, 2.27)
  46–64 years 1.35 (0.94, 1.93)
Race
  Non-Hispanic white Ref
  Non-Hispanic black 1.20 (0.91, 1.58)
  Other 0.69 (0.43, 1.11)
Critical congenital heart defect
  No Ref
  Yes 1.56 (1.17, 2.08)
Sex
  Male Ref
  Female 0.93 (0.77, 1.13)
Expected payer at first visit
  Public 1.50 (1.20, 1.88)
  Private Ref
  Other 1.06 (0.79, 1.41)
Residence at first visit
  Rural Ref
  Urban 1.05 (0.86, 1.29)
Cardiac procedurea
  No Ref
  Yes 0.96 (0.78, 1.19)
No. of comorbiditiesc
  0 comorbidities Ref
  1 comorbidity 1.60 (1.19, 2.17)
  2 comorbidities 4.35 (3.17, 5.96)
  3+ comorbidities 13.69 (10.10, 18.54)
Bolded text indicates significant at P < 0.05 level; model adjusted for all variables listed in table as well as year at first hospitalization. Excludes 
288 patients who died during their first hospitalization or who were admitted for the first time in 2011.
a
At least one inpatient cardiac procedure during any hospitalization.
b
Comorbidities defined using the Elixhauser comorbidity measures; separate comorbid conditions were counted once regardless of the number of 
hospitalizations in which they were diagnosed.
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